Deep Health AI India Q2 FY27 Results: Net Profit ₹0.2 Cr, Down 92.0% YoY
Deep Health AI India Ltd reported revenue from operations of ₹0.5 Cr (-85.3% YoY) and net profit of ₹0.2 Cr (-92.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.2 Cr · -92.0% YoY
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
34 announcements
Deep Health AI India Ltd reported revenue from operations of ₹0.5 Cr (-85.3% YoY) and net profit of ₹0.2 Cr (-92.0% YoY) for Q2 FY27.
Deep Health AI amended its MoU to acquire Pune agricultural land, revising consideration to Rs. 19.50 Crore. Completion is extended by one year under the revised terms.
Deep Health AI will hold a board meeting on 3 November 2026 for unaudited quarterly and half-year results. Trading window stays closed until 48 hours after results.
Deep Health AI India Ltd filed its quarterly shareholding pattern for the quarter ended September 30, 2026, as per regulatory requirements.
Deep Health AI India Limited acquired debt and underlying security from Kshitij Polyline Limited for ₹10.35 Crore. The assignment secures rights in Sparion Infrastructure Private Limited.
Deep Health AI India Limited appointed Virendra Choubisa as Non-Executive Director and M/s Vimal C Surana as statutory auditor, replacing outgoing auditor M/s VRSK & Co. LLP.
Deep Health AI India Limited successfully concluded its 32nd Annual General Meeting on September 30, 2026, where all proposed resolutions were passed by the members.
Deep Health AI India Limited has announced the resignation of Mr. Rajesh Nandkishore Pherwani as a Non-Executive Independent Director, effective September 11, 2026.
Deep Health AI India sent a Reg 36(1)(b) letter to shareholders with unregistered emails, providing the Annual Report FY25-26 weblink and AGM e-voting details. No financial or business substance is disclosed.
Deep Health AI India Limited has released its 32nd Annual Report for the financial year 2025-2026, including the notice of its upcoming Annual General Meeting.
Deep Health AI India Limited has issued the notice for its 32nd Annual General Meeting scheduled for September 30, 2026. The agenda includes financial statement adoption.
Deep Health AI India Limited has appointed Mr. Virendra Choubisa as an Independent Director and M/s Vimal C Surana and Company as the new Statutory Auditor.
Deep Health AI India Limited held its board meeting, approving the 32nd AGM, a new director appointment, and a new statutory auditor appointment.
Deep Health AI India Ltd reported revenue from operations of ₹0.5 Cr (+400.0% YoY) and a net loss of ₹2.1 Cr for Q1 FY27.
Deep Health AI India Ltd has scheduled a Board Meeting on August 13, 2026, to consider and approve its un-audited standalone and consolidated financial results.
Deep Health AI India Limited announced the appointment of Mr. Bhupesh Swami and Mrs. Shashi Kala Dhabriya as Non-Executive Independent Directors on the Board.
Deep Health AI India held its 1st Extra-Ordinary General Meeting on July 30, 2026. Shareholders passed all resolutions, including the appointment of two independent directors.
Deep Health AI India entered an MoU to acquire 49,100 sq. mtr. of land in Pune. The company paid a Rs. 2.85 Crore advance.
Deep Health AI India submitted a revised Auditor's Report for FY26 to include previously omitted entity names. The correction has no financial impact.
Deep Health AI India Ltd. will hold an EGM on July 30, 2026, for shareholder approvals. E-voting opens July 27, 2026, for members on record as of July 23, 2026.
Deep Health AI India Ltd board approved calling an EGM on July 30, 2026. The meeting was held via video conferencing on July 2, 2026.
Deep Health AI India appointed Mr. Bhupesh Swami as an Additional Independent Director. His term runs for two years from July 2, 2026.
Deep Health AI acquired a 6.37% stake in Leapfrog Engineering Services Ltd. The acquisition cost was ₹19.92 Crore.
Deep Health AI India approved audited financial results for FY26. The company also appointed M/s. Valawat & Associates as Internal Auditors for the 2026-2027 fiscal year.
Deep Health AI India Ltd reported revenue from operations of ₹0.2 Cr (-60.0% YoY) and a net loss of ₹4.5 Cr for Q4 FY26.
Deep Health AI India Limited reported FY26 total income of ₹8.49 Crore. The board also approved appointing M/s. Valawat & Associates as internal auditors for FY27.
Deep Health AI India Ltd fully utilized ₹39.98 Crore raised via a Rights Issue. Proceeds were primarily diverted to equity investments in other companies.
Deep Health AI India Limited filed its FY 2026 Annual Secretarial Compliance Report. The report notes a ₹7,080 fine for a minor procedural filing delay.
Deep Health AI India Limited deferred its board meeting to May 29, 2026. The postponement allows management to seek further clarifications regarding audited financial results.
Deep Health AI India Limited scheduled a May 27 board meeting to approve audited FY26 financial results. Trading window remains closed for designated persons.